TCL Archive DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio January 1, 1988
TCL Archive RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers September 11, 1992
TCL Archive Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.” July 18, 2008
TCL Archive Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program November 29, 2002
